Serum Interleukin-23/17 Levels in Ankylosing Spondylitis Patients Treated with Nonsteroidal Anti-Inflammatory Drugs: A Prospective Cohort Study

Etiopathogenesis of ankylosing spondylitis (AS), a major subtype of a group of chronic inflammatory diseases known as spondyloarthropathies, is not clearly understood yet. In this study, we aimed to investigate the interleukin 23 (IL-23)/interleukin-17 (IL-17) pathway, which is a new cytokine pathwa...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of interferon & cytokine research 2019-09, Vol.39 (9), p.572-576
Hauptverfasser:	Deveci, Hulya, Caglıyan Turk, Ayla, Ozmen, Zeliha Cansel, Deveci, Koksal
Format:	Artikel
Sprache:	eng
Schlagworte:	Ankylosing spondylitis Anti-inflammatory agents Cohort analysis Cytokines Disease control Drugs Health risk assessment Inflammatory diseases Interleukin 17 Interleukin 23 Interleukin 6 Nonsteroidal anti-inflammatory drugs Patients Spondylitis Spondyloarthropathy Tumor necrosis factor-TNF Tumor necrosis factor-α
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!